EPO: Cost-Effectiveness
The positive effects of EPO therapy include not only higher mean hematocrits in treated patients, but also an improvement in exercise tolerance, reduced left ventricular hypertrophy and quality of life
The relative risk of hospitalization and mortality is lower in ESRD patients who achieve a target hematocrit of 33-36% as compared with lower hematocrit ranges
Ma JZ et al. J Am Soc Nephrol 1999;10:610-619
Xia H et al. J Am Soc Nephrol 1999;10:1309-16